Sculptor Capital Management Inc (SCU)

US8112461079 - Common Stock

12.72  -0.03 (-0.24%)

After market: 12.73 +0.01 (+0.08%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SCU. SCU was compared to 208 industry peers in the Capital Markets industry. SCU has a bad profitability rating. Also its financial health evaluation is rather negative. SCU has a correct valuation and a medium growth rate.



1

1. Profitability

1.1 Basic Checks

SCU had positive earnings in the past year.
In the past year SCU has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: SCU reported negative net income in multiple years.
SCU had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -0.66%, SCU is doing worse than 81.37% of the companies in the same industry.
Industry RankSector Rank
ROA -0.66%
ROE N/A
ROIC N/A
ROA(3y)3.18%
ROA(5y)2.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SCU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

SCU has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, SCU has less shares outstanding
SCU has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.18, we must say that SCU is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.18, SCU is not doing good in the industry: 75.49% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.18
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

SCU has a Current Ratio of 0.63. This is a bad value and indicates that SCU is not financially healthy enough and could expect problems in meeting its short term obligations.
SCU's Current ratio of 0.63 is on the low side compared to the rest of the industry. SCU is outperformed by 72.06% of its industry peers.
SCU has a Quick Ratio of 0.63. This is a bad value and indicates that SCU is not financially healthy enough and could expect problems in meeting its short term obligations.
SCU's Quick ratio of 0.63 is on the low side compared to the rest of the industry. SCU is outperformed by 72.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.63

5

3. Growth

3.1 Past

The earnings per share for SCU have decreased strongly by -31.88% in the last year.
SCU shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -28.70% yearly.
Looking at the last year, SCU shows a very negative growth in Revenue. The Revenue has decreased by -32.74% in the last year.
Measured over the past years, SCU shows a very negative growth in Revenue. The Revenue has been decreasing by -13.36% on average per year.
EPS 1Y (TTM)-31.88%
EPS 3Y-32.82%
EPS 5Y-28.7%
EPS growth Q2Q128.8%
Revenue 1Y (TTM)-32.74%
Revenue growth 3Y-11.15%
Revenue growth 5Y-13.36%
Revenue growth Q2Q-36.82%

3.2 Future

The Earnings Per Share is expected to grow by 64.97% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 31.87% on average over the next years. This is a very strong growth
EPS Next Y75.46%
EPS Next 2Y64.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25.62%
Revenue Next 2Y31.87%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.53 indicates a correct valuation of SCU.
SCU's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.42, SCU is valued a bit cheaper.
SCU is valuated cheaply with a Price/Forward Earnings ratio of 4.97.
96.57% of the companies in the same industry are more expensive than SCU, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.74. SCU is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.53
Fwd PE 4.97

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SCU's earnings are expected to grow with 64.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y64.97%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

SCU has a Yearly Dividend Yield of 2.83%. Purely for dividend investing, there may be better candidates out there.
SCU's Dividend Yield is slightly below the industry average, which is at 7.69.
Compared to an average S&P500 Dividend Yield of 2.34, SCU pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.83%

5.2 History

The dividend of SCU is nicely growing with an annual growth rate of 22.64%!
SCU has been paying a dividend for at least 10 years, so it has a reliable track record.
SCU has decreased its dividend recently.
Dividend Growth(5Y)22.64%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

The earnings of SCU are negative and hence is the payout ratio. SCU will probably not be able to sustain this dividend level.
The dividend of SCU is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-114.51%
EPS Next 2Y64.97%
EPS Next 3YN/A

Sculptor Capital Management Inc

NYSE:SCU (11/16/2023, 7:04:00 PM)

After market: 12.73 +0.01 (+0.08%)

12.72

-0.03 (-0.24%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap852.49M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.83%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 13.53
Fwd PE 4.97
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.18
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.66%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.63
Quick Ratio 0.63
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-31.88%
EPS 3Y-32.82%
EPS 5Y
EPS growth Q2Q
EPS Next Y75.46%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-32.74%
Revenue growth 3Y-11.15%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y